Product index

A focused injectable portfolio, ready for global partners.

Discover assets across development and commercial stages, supported by documentation and execution discipline needed for regulated and emerging markets.

Filters
Therapy
Dosage form
Product status
Anti-Infective
Antibiotic
Antifungal
CNS
COX- 2 inhibhitor
& NSAID
COX-2 Inhibitor
CVS
Metabolic Disorders
Oncology
Parental nutrition
Test Therapy
Emulsion
IR Vial - Dry Lyophilised
Liquid
Liquid (room temp)
Liquid vial
Lyophilised
Test Dosage
Dossier Readiness 
DATE- READY
Approved in US & ROW
Commercialised 
in US & ROW
Select
Anti-Infective
Antibiotic
Antifungal
CNS
COX- 2 inhibhitor
& NSAID
COX-2 Inhibitor
CVS
Metabolic Disorders
Oncology
Parental nutrition
Test Therapy
Select
Emulsion
IR Vial - Dry Lyophilised
Liquid
Liquid (room temp)
Liquid vial
Lyophilised
Test Dosage
Select
Dossier Readiness 
DATE- READY
Approved in US & ROW
Commercialised 
in US & ROW
6 of 14 products
Product Therapy Dosage Phase 1:
INITIAL DISCOVERY
Phase 2:
PROTOTYPE COMPLETION
Phase 3:
EXHIBIT BATCH STAGE
Phase 4:
DOSSIER READY
Phase 5:
FILED / COMMERCIALISED
Decitabine Oncology Lyophilised
Parecocib COX-2 Inhibitor Lyophilised
Sugammadex CNS Liquid
Tigecycline Antibiotic Lyophilised
Posaconazole Antifungal Liquid
Isavuconazole Antifungal Lyophilised

Decitabine

Therapy Oncology
Dosage Lyophilised
Phase Phase 5 – FILED / COMMERCIALISED

Parecocib

Therapy COX-2 Inhibitor
Dosage Lyophilised
Phase Phase 5 – FILED / COMMERCIALISED

Sugammadex

Therapy CNS
Dosage Liquid
Phase Phase 5 – FILED / COMMERCIALISED

Tigecycline

Therapy Antibiotic
Dosage Lyophilised
Phase Phase 1 – INITIAL DISCOVERY

Posaconazole

Therapy Antifungal
Dosage Liquid
Phase Phase 4 – DOSSIER READY

Isavuconazole

Therapy Antifungal
Dosage Lyophilised
Phase Phase 4 – DOSSIER READY

Built for
adoption

Tech transfer products
designed for real-world delivery.

Ready-to-transfer packages backed by disciplined development and documentation, so partners can move from handover to production with confidence.